Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...

Joe Bidens cancer diagnosis has raised big questions about his health and future. At 82, the former president is battling ...

EXCLUSIVE: A leading authority in prostate treatment and urology has given his insights on a condition that can affect 1 in 8 ...

Former United States president Joe Biden has been forced to clarify his cancer timeline following the Donald Trump cover-up ...

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...